AAAAAA

   
Results: 1-3 |
Results: 3
TNF NEUTRALIZATION DOES NOT CAUSE AUTOANTIBODY CHANGES - THE EXPERIENCE WITH 521 PATIENTS ENROLLED INTO IV RO-45-2081 TRIALS
Authors: WEISMAN MH MARKENSON J WIIK A ZAUG M DURRWELL L VANDERAUWERA P STEVENS RM
Citation: Mh. Weisman et al., TNF NEUTRALIZATION DOES NOT CAUSE AUTOANTIBODY CHANGES - THE EXPERIENCE WITH 521 PATIENTS ENROLLED INTO IV RO-45-2081 TRIALS, Arthritis and rheumatism, 40(9), 1997, pp. 304-304
CHRONIC TNF NEUTRALIZATION (UP TO 1-YEAR) BY LENERCEPT (TNFR55-IGG1, RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RESULTS OF AN OPEN-LABEL EXTENSION OF A DOUBLE-BLIND SINGLE-DOSE PHASE-I STUDY
Authors: HASLER F VANDEPUTTE L BAUDIN M LUDIN E DURRWELL L MCAULIFFE T VANDERAUWERA P
Citation: F. Hasler et al., CHRONIC TNF NEUTRALIZATION (UP TO 1-YEAR) BY LENERCEPT (TNFR55-IGG1, RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RESULTS OF AN OPEN-LABEL EXTENSION OF A DOUBLE-BLIND SINGLE-DOSE PHASE-I STUDY, Arthritis and rheumatism, 39(9), 1996, pp. 1292-1292
LOADING MAINTENANCE DOSES APPROACH TO NEUTRALIZATION OF TNF BY LENERCEPT (TNFR55-IGG1, RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED FOR 3 MONTHS - RESULTS OF A DOUBLEBLIND PLACEBO-CONTROLLED PHASE-II TRIAL/
Authors: CUTOLO M KIRKHAM B BOLOGNA C SANY J SCOTT D BROOKS P FORRE O JAIN R KVIEN T MARKENSON J SEIBOLD J STURROCK R VEYS E EDWARDS J ZAUG M DURRWELL L BISSCHOPS C CLAIR PS MILNARIK P BAUDIN M VANDERAUWERA P
Citation: M. Cutolo et al., LOADING MAINTENANCE DOSES APPROACH TO NEUTRALIZATION OF TNF BY LENERCEPT (TNFR55-IGG1, RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED FOR 3 MONTHS - RESULTS OF A DOUBLEBLIND PLACEBO-CONTROLLED PHASE-II TRIAL/, Arthritis and rheumatism, 39(9), 1996, pp. 1294-1294
Risultati: 1-3 |